IDH1 and central nervous system cancer: IDH1-mutant gliomas have lower cell density, lower tissue complexity, and less aggressiveness, so they have decreased MK values, while IDH1 wild-type gliomas have a more heterogeneous tissue microenvironment, higher cell density, and more aggressive phenotype, resulting in significantly increased MK values.